USA Financial Formulas’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,117
Closed -$170K 463
2025
Q4
$170K Sell
2,117
-536
-20% -$43.1K 0.03% 145
2025
Q3
$218K Sell
2,653
-534
-17% -$46.3K 0.04% 135
2025
Q2
$291K Buy
3,187
+761
+31% +$68K 0.05% 102
2025
Q1
$222K Buy
2,426
+351
+17% +$30.6K 0.04% 132
2024
Q4
$177K Sell
2,075
-90
-4% -$7.9K 0.03% 175
2024
Q3
$189K Sell
2,165
-242
-10% -$20.4K 0.03% 159
2024
Q2
$190K Sell
2,407
-225
-9% -$18.5K 0.03% 167
2024
Q1
$238K Sell
2,632
-685
-21% -$62.4K 0.04% 172
2023
Q4
$292K Buy
3,317
+3,297
+16,485% +$275K 0.05% 120
2023
Q3
$1.69K Buy
+20
New +$1.81K ﹤0.01% 345
2023
Q2
Sell
-7
Closed -$672 496
2023
Q1
$672 Buy
+7
New +$648 ﹤0.01% 329
2022
Q3
$181K Buy
+2,278
New +$193K 0.29% 58
2020
Q1
Sell
-12,518
Closed -$904K 238
2019
Q4
$904K Buy
+12,518
New +$853K 0.38% 69

Other funds holding DOX

USA Financial Formulas's DOX Position: Q1 2026 in Review

USA Financial Formulas sold out of Amdocs (DOX) in Q1 2026, closing a stake of 2,117 shares — an estimated $170K sold.

USA Financial Formulas first reported a position in DOX in Q4 2019 and held it in 13 quarters. The position peaked at $904K in Q4 2019. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • USA Financial Formulas reported no remaining Amdocs position as of Q1 2026 after selling out during the quarter.
  • USA Financial Formulas sold 2,117 Amdocs shares in Q1 2026, an estimated $170K.
  • USA Financial Formulas first reported a position in Amdocs in Q4 2019 and held it in 13 quarters.
  • USA Financial Formulas's Amdocs position peaked at $904K in Q4 2019.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.